Standout Papers

Clinical Practice Guidelines for the Management C... 1994 2026 2004 2015 2.3k
  1. Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America (2009)
    Peter G. Pappas, Carol A. Kauffman et al. Clinical Infectious Diseases
  2. Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus (2002)
    Sibel Aşçıoğlu, John Rex et al. Clinical Infectious Diseases
  3. Guidelines for Treatment of Candidiasis (2004)
    Peter G. Pappas, John Rex et al. Clinical Infectious Diseases
  4. A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia (1994)
    John Rex, John E. Bennett et al. New England Journal of Medicine
  5. Resistance of Candida species to fluconazole (1995)
    John Rex, M G Rinaldi et al. Antimicrobial Agents and Chemotherapy
  6. Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections (1997)
    John Rex, Michael A. Pfaller et al. Clinical Infectious Diseases
  7. Practice Guidelines for the Treatment of Candidiasis (2000)
    John Rex, Thomas J. Walsh et al. Clinical Infectious Diseases
  8. A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients (2003)
    Peter G. Pappas, John Rex et al. Clinical Infectious Diseases
  9. Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials (2012)
    David R. Andes, Nasia Safdar et al. Clinical Infectious Diseases
  10. Social Behaviour, Its Elementary Forms (1962)
    John Rex, George C. Homans British Journal of Sociology
  11. Antibiotic development — economic, regulatory and societal challenges (2019)
    Christine Årdal, Manica Balasegaram et al. Nature Reviews Microbiology
  12. Critical analysis of antibacterial agents in clinical development (2020)
    Ursula Theuretzbacher, Karen Bush et al. Nature Reviews Microbiology
  13. Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed. (2022)
    Mark S. Butler, Valeria Gigante et al. Oxford University Research Archive (ORA) (University of Oxford)

Immediate Impact

5 by Nobel laureates 7 from Science/Nature 165 standout
Sub-graph 1 of 16

Citing Papers

Multidrug-resistant Gram-negative bacterial infections
2025 Standout
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
2024 Standout
12 intermediate papers

Works of John Rex being referenced

Patient Access in 14 High-Income Countries to New Antibacterials Approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and Medical Devices Agency, or Health Canada, 2010–2020
2021
White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-Spectrum Indications, and Unmet Needs
2017
and 10 more

Author Peers

Author Last Decade Papers Cites
John Rex 18457 14758 2237 2307 288 27.2k
John R. Wingard 13384 13803 1597 2043 430 32.6k
John E. Edwards 16107 12370 2764 4365 218 26.2k
Po‐Ren Hsueh 14841 12286 3170 5321 960 36.9k
Eleftherios Mylonakis 9024 7445 1277 5235 422 21.5k
Jeremy Farrar 21018 9371 573 4492 450 43.8k
Steven M. Holland 11686 14878 896 7401 710 46.1k
Matthew E. Falagas 7924 15007 7753 5643 589 46.4k
Didier Pittet 21072 9694 1228 2799 562 41.8k
Arturo Casadevall 26052 27624 1572 12174 872 51.6k
Richard D. Moore 15983 12088 1987 1243 618 29.7k

All Works

Loading papers...

Rankless by CCL
2026